BioCryst Pharmaceuticals (BCRX) Fails to deliver data

Key failure to deliver metrics for BioCryst Pharmaceuticals :

• Last SEC data release: 2025-01-14
• Last 15 days FTD volume: NZ$0.04 M
• Last 3 months FTD volume: NZ$0.41 M
• Last year FTD volume: NZ$0.41 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioCryst Pharmaceuticals (BCRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioCryst Pharmaceuticals (BCRX) - since 2013

BioCryst Pharmaceuticals (BCRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Repligen RGEN	NZ$2.55 M	NZ$34.77 M	🇺🇸 USA
Sarepta Therapeutics SRPT	NZ$9.54 M	NZ$41.32 M	🇺🇸 USA
NanoViricides NNVC	NZ$2.71 M	NZ$5.64 M	🇺🇸 USA
Novavax NVAX	NZ$27.93 M	NZ$0.14 B	🇺🇸 USA
Gilead Sciences GILD	NZ$31.81 M	NZ$0.12 B	🇺🇸 USA
Celldex Therapeutics CLDX	NZ$1.73 M	NZ$6.25 M	🇺🇸 USA
GlaxoSmithKline GSK	NZ$95.08 M	NZ$0.14 B	🇬🇧 UK
Emergent BioSolutions EBS	NZ$1.17 M	NZ$5.98 M	🇺🇸 USA
Cel-Sci CVM	NZ$0.66 M	NZ$2.85 M	🇺🇸 USA